公司概覽
業務類別 Biotechnology
業務概覽 Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Itspipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
公司地址 3115 Merryfield Row, Suite 300, San Diego, CA, USA, 92121
電話號碼 +1 858 465-6511
傳真號碼 --
公司網頁 https://www.erasca.com
員工數量 103
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ebun S. Garner Chief Legal Officer and Corporate Secretary -- 28/04/2026
Dr. Jonathan E. Lim,M.D. Chairman of the Board and Chief Executive Officer 美元 670.40K 28/04/2026
Dr. Shannon R. Morris, M.D.,PhD Chief Medical Officer 美元 515.00K 28/04/2026
Dr. Charles S. Fuchs, M.D.,M.P.H. President, Research and Development -- 10/08/2026
Dr. David M. Chacko, M.D. Chief Financial Officer, Principal Accounting Officer and Chief Business Officer 美元 516.70K 28/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Alexander W. Casdin Independent Director 28/04/2026
Ms. Jean I. Liu, J.D. Independent Director 28/04/2026
Dr. Jonathan E. Lim,M.D. Chairman of the Board and Chief Executive Officer 28/04/2026
Dr. Julie Hambleton, M.D. Independent Director 28/04/2026
Dr. Pratik S. Multani, M.D. Independent Director 28/04/2026
Dr. James A. Bristol, PhD Lead Independent Director 28/04/2026
Dr. Michael D. Varney, PhD Director and Chair of Research and Development 28/04/2026
Dr. Valerie Harding Start, PhD Independent Director 28/04/2026
 
所屬ETF (更新日期: 14/11/2026 03:37)
代號 名稱 佔比% ▼ 持有日期
PRFZInvesco RAFI US 1500 Small-Mid ETF0.03%30/10/2026
TMSLT. Rowe Price Small-Mid Cap ETF0.03%31/10/2026
FHLCFidelity MSCI Health Care ETF0.03%30/10/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.02%30/10/2026
ONEQFidelity Nasdaq Composite ETF0.02%30/10/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.02%30/10/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.02%30/10/2026
IWViShares Russell 3000 ETF0.02%30/10/2026
ISCViShares Morningstar Small-Cap Value ETF0.01%30/10/2026
FSCCFederated Hermes MDT Small Cap Core ETF0.01%30/10/2026
DFUSDimensional US Equity Market ETF0.01%30/10/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%30/10/2026
QQQXNuveen NASDAQ 100 Dynamic Overwrite0.01%30/09/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.01%30/10/2026
BBCVirtus Biotech Clinical Trials ETF0.01%30/10/2026
DFAUDimensional US Core Equity Market ETF0.01%30/10/2026
VTHRVanguard Russell 3000 ETF0.01%30/09/2026
TMEDT. Rowe Price Health Care ETF0.01%31/10/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%30/10/2026
ITWOProShares Russell 2000 High Income ETF0.004%30/10/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.